BioQ Pharma
Private Company
Total funding raised: $17.5M
Overview
BioQ Pharma is a commercial-stage biotech company developing and commercializing proprietary, pre-filled, ready-to-use infusion systems for hard-to-prepare drugs. Its core invenious™ platform is designed to enhance safety, sterility, and convenience while reducing medication errors and total cost of care. The company has launched its first product, Ropivacaine Readyfusor, for post-surgical pain and is building a pipeline across anesthesia, sedation, antibiotics, and oncology.
Technology Platform
invenious™: A proprietary, ready-to-use, connect-and-go delivery platform for infusible drugs. It features pre-filled, unit-dose, drug-specific systems designed to enhance safety, sterility, and convenience by eliminating manual preparation steps at the point of care.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
BioQ competes in the drug delivery device space, facing potential competition from large infusion pump companies (e.g., Becton Dickinson, Baxter) that may develop integrated systems, and other specialty pharmaceutical companies focusing on ready-to-use formulations. Its differentiation lies in its dedicated, adaptable platform designed specifically for hard-to-prepare infusibles.